Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
Virginia Governor Glenn Youngkin named BIO’s…
WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and…
New Season of “I am BIO” Podcast Explores Patient…
WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…
BIO Statement On Selected Drugs in Medicare under…
The Biotechnology Innovation Organization (BIO) released the following statement after today’s announcement from the Centers for Medicare & Medicaid Services (CMS) on selected drugs under the Inflation Reduction Act (IRA):“While the Inflation…
All Press Releases
  • Show All
Search
Results
Event Tags
July 16, 2020
In response to attacks on Dr. Anthony Fauci’s credibility and character, BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement: “As this global pandemic continues to wreak havoc, we must stand behind the scientists and…
July 9, 2020
Today more than 20 leading biopharmaceutical companies announced the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as the threat of antimicrobial resistance, or…
July 8, 2020
Washington, D.C. (July 8, 2020)—The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO IMPACT Ag & Environment Conference scheduled for September 21-22 to an online platform, instead of convening an in…
June 30, 2020
Congressional Action Plan Released Today Incorporates Key BIO Recommendations Washington, D.C. (June 30, 2020) – Cleaner air, healthier soils, and improved human health – goals of a Congressional climate crisis action plan released today – are just…
June 29, 2020
Tom DiLenge, President, Advocacy, Law and Public Policy, of the Biotechnology Innovation Organization (BIO), released the following statement regarding the prescription drug provisions in the Patient Protection and Affordable Care Enhancement Act …
June 26, 2020
Washington, DC – (June 26, 2020) – The Biotechnology Innovation Organization (BIO) today announced winners of the Start-up Stadium competition held during BIO Digital in June. Pre-recorded presentation videos submitted by 30 finalists were…
June 24, 2020
Washington, D.C. (June 24, 2020)—The Biotechnology Innovation Organization issued the following statement on today’s hearing on the Growing Climate Solutions Act: “The importance of today’s discussion cannot be understated. Climate change is a…
June 23, 2020
BIO Board Member Dr. Gerberding to testify this morning The Senate Committee on Health, Education, Labor and Pensions, chaired by Senator Lamar Alexander, will hold an important hearing today to examine lessons learned from the current global…
June 17, 2020
BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement in advance of a congressional subcommittee hearing in the House Committee on Energy and Commerce on racial and ethnic disparities in Covid-19:   “The…
June 16, 2020
The Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Executive Committee members for the 2020-2021 term. Additionally, eight new board directors and four new section governing board chairs and vice chairs…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.